The treatment of Dupuytren disease.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 21527148.
- Also identified by DOI 10.1016/j.jhsa.2011.03.002.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The treatment of progressive Dupuytren contractures has historically been and continues to be largely surgical. Although a number of surgical interventions do exist, limited palmar fasciectomy continues to be the most common and widely accepted treatment option. Until recently, nonsurgical options were limited and clinically ineffective. However, the commercial availability and recent approval of collagenase clostridium histolyticum now provides practitioners with a nonsurgical approach to this disease. This article presents a comprehensive review of the surgical and nonsurgical treatments of Dupuytren disease, with a focus on collagenase.
Medical subject headings
- Dupuytren Contracture
- Fasciotomy
- Microbial Collagenase